Novabay Stock Soars 10.07% on Special Dividend Announcement

On September 4, 2025, Novabay's stock surged by 10.07% in pre-market trading, driven by a series of positive developments that have captured investor attention.

One of the key factors contributing to the stock's rise is the company's recent announcement of an $0.80 per share special dividend, which is set to be paid on September 30, 2025. This dividend, combined with the company's historically negative earnings, has added to its short-term appeal, attracting investors looking for immediate returns.

Additionally, Novabay Pharmaceuticals has seen significant gains following the announcement of a special cash dividend. This move has been well-received by the market, further boosting investor confidence in the company's financial health and future prospects.

Looking ahead, earnings for Novabay Pharmaceuticals are expected to improve in the coming year, with projections indicating a shift from a loss of $3.26 per share to a loss of $0.86 per share. This anticipated improvement in earnings, coupled with the recent dividend announcements, has positioned Novabay as an attractive investment option for those seeking both short-term gains and long-term growth potential.